The balance between gasdermin D and STING signaling shapes the severity of schistosome immunopathology.
Parisa KalantariIlana ShecterJacob HopkinsAndrea Pilotta GoisYoelkys MoralesBijan F HarandiShruti SharmaMiguel J StadeckerPublished in: Proceedings of the National Academy of Sciences of the United States of America (2023)
There is significant disease heterogeneity among mouse strains infected with the helminth Schistosoma mansoni . Here, we uncover a unique balance in two critical innate pathways governing the severity of disease. In the low-pathology setting, parasite egg-stimulated dendritic cells (DCs) induce robust interferon (IFN)β production, which is dependent on the cyclic GMP-AMP synthase (cGAS)/stimulator of interferon genes (STING) cytosolic DNA sensing pathway and results in a Th2 response with suppression of proinflammatory cytokine production and Th17 cell activation. IFNβ induces signal transducer and activator of transcription (STAT)1, which suppresses CD209a, a C-type lectin receptor associated with severe disease. In contrast, in the high-pathology setting, enhanced DC expression of the pore-forming protein gasdermin D (Gsdmd) results in reduced expression of cGAS/STING, impaired IFNβ, and enhanced pyroptosis. Our findings demonstrate that cGAS/STING signaling represents a unique mechanism inducing protective type I IFN, which is counteracted by Gsdmd.
Keyphrases
- dendritic cells
- immune response
- regulatory t cells
- poor prognosis
- binding protein
- single cell
- escherichia coli
- magnetic resonance
- cell therapy
- cell proliferation
- single molecule
- stem cells
- gene expression
- staphylococcus aureus
- nuclear factor
- protein protein
- early onset
- toll like receptor
- pseudomonas aeruginosa
- protein kinase
- candida albicans
- biofilm formation
- contrast enhanced